Abstract Within steroid receptor heterocomplexes the large tetratricopeptide repeat-containing immunophilins, cyclophilin 40 (CyP40), FKBP51, and FKBP52, target a common interaction site in heat shock protein 90 (Hsp90) and act coordinately with Hsp90 to modulate receptor activity. The reversible nature of the interaction between the immunophilins and Hsp90 suggests that relative cellular abundance might be a key determinant of the immunophilin component within steroid receptor complexes. To investigate CyP40 gene regulation, we have isolated a 5-kilobase (kb) 5Ј-flanking region of the human gene and demonstrated that a ϳ50 base pair (bp) sequence adjacent to the transcription start site is essential for CyP40 basal expression. Three tandemly arranged Ets sites within this critical region were identified as binding elements for the multimeric Ets-related transcription factor, GA binding protein (GABP). Functional studies of this proximal promoter sequence, in combination with mutational analysis, confirmed these sites to be crucial for basal promoter function. Furthermore, overexpression of both GABP␣ and GABP␤ subunits in Cos1 cells resulted in increased endogenous CyP40 mRNA levels. Significantly, a parallel increase in FKBP52 mRNA expression was not observed, highlighting an important difference in the mode of regulation of the CyP40 and FKBP52 genes. Our results identify GABP as a key regulator of CyP40 expression. GABP is a common target of mitogen and stress-activated pathways and may integrate these diverse extracellular signals to regulate CyP40 gene expression.
INTRODUCTION
Cyclophilins and FK506 binding proteins (FKBPs) are cellular targets for the immunosuppressive drugs, cyclosporin A and FK506, respectively, and display a peptidylprolyl isomerase (PPIase) function that is believed to catalyze protein folding (Galat and Metcalfe 1995) . Human cyclophilin 40 (CyP40; Kieffer et al 1993) and its bovine homolog (Ratajczak et al 1993) were cloned from respective cDNA libraries in 1993. First identified in association with the unactivated estrogen receptor (Ratajczak et al 1990 (Ratajczak et al , 1993 , CyP40 is also present in assembled glucocorticoid and progesterone receptor complexes (Smith et al 1993a (Smith et al , 1993b Hutchison et al 1994; Johnson and Toft 1995; Smith et al 1995; Chen et al 1996; Prapapanich et al 1996; Dittmar et al 1997) and shares sequence homology with FKBP51 and FKBP52, additional components of apo steroid receptors (Tai et al 1986; Renoir et al 1990; Nair et al 1997) . There is accumulating evidence that these immunophilins have a coordinate role with the Hsp90 chaperone machinery in the assembly, subcellular trafficking, and function of steroid receptors (Czar et al 1995; Duina et al 1996; Pratt and Toft 1997) . The immunophilins compete directly for a common tetratricopeptide repeat (TPR) acceptor site in Hsp90, resulting in the formation of distinct immunophilin-Hsp90-receptor complexes (OwensGrillo et al 1995; Ratajczak and Carrello 1996; Nair et al 1997) . This common recognition site has been localized to a discrete C-terminal domain of Hsp90 (Carrello et al 1999) , a region that mediates Hsp90 chaperone and dimerization functions (Nemoto et al 1995 (Nemoto et al , 1997 Young et al 1997; Nemoto and Sato 1998; Scheibel et al 1998; Car-rello et al 1999) and contains structural elements that are important for steroid receptor interaction (Sullivan and Toft 1993; Meng et al 1996) . Despite the similarities in molecular architecture between the immunophilins, there are recent indications that unique features within their TPR domains and adjacent subregions allow distinct interactions with Hsp90 that lead to different functional consequences for receptor activity (Nair et al 1997; Barent et al 1998; Chen et al 1998; Reynolds et al 1999) . The selection of immunophilin within steroid receptor complexes may then provide an additional means of modulating hormonal response. Although there is evidence for a preferential association of FKBP51 with progesterone and glucocorticoid receptors during cell-free assembly reactions (Nair et al 1997; Barent et al 1998) , the possibility remains that the relative cellular abundance of the immunophilins is a key determinant of immunophilin-receptor association in vivo.
The steroid receptor-associated immunophilins are ubiquitously expressed in human tissues (Nair et al 1997) .
In a recent study, we have shown that CyP40 and FKBP52 are universally but variably expressed in breast carcinomas and breast cancer cell lines and that they are elevated in breast cancer compared with normal breast tissue (Ward et al 1999) . FKBP51 displays an increased temporal pattern of expression during the early clonal expansion phase of adipocyte differentiation (Yeh et al 1995) and is up-regulated by glucocorticoids (Baughman et al 1997) . Evidence of mitogen-induced expression of FKBP52 mRNA expression suggests this immunophilin may be associated with important mechanisms that control cell growth (Doucet-Brutin et al 1995) . The wis 2ϩ gene of the yeast Schizosaccharomyces pombe, shown to have significant sequence similarity to mammalian CyP40, is heat shockinduced (Weisman et al 1996) . Our own results have shown a marked increase in CyP40 mRNA expression in MCF-7 breast cancer cells exposed to heat and chemical stress (Mark et al 2001) , indicating that similar to FKBP52 (Sanchez 1990) , CyP40 belongs to the family of stressinducible proteins. Consistent with our observations, Yokoi et al (1996) have identified a putative heat shock element located in the first intron of the CyP40 gene.
With the likely influences of CyP40 and its partner immunophilins on Hsp90 and steroid receptor function, we have begun to study the regulation of these genes. Here we describe the isolation of a 5 kb 5Ј-flanking segment of the CyP40 gene, and the functional characterization of the CyP40 proximal promoter. Using transient cell transfection assays and stepwise 5Ј deletion constructs of the CyP40 promoter, we have mapped the minimal promoter to a region approximately Ϫ51 bp upstream of the main transcription start site. This region, which incorporates 3 Ets sites, is essential for basal promoter activity. We demonstrate that GA-binding protein (GABP), a heteromeric Ets-related transcription factor, specifically binds to these sites. The role of GABP in CyP40 gene regulation was confirmed by observations that coexpression of GABP␣ and GABP␤ subunits in mammalian cells promoted increased activation of the CyP40 minimal promoter and enhanced the expression of endogenous CyP40 mRNA. Collectively, these results provide novel insights into the mechanisms that control the basal expression of CyP40.
MATERIALS AND METHODS

CyP40 promoter isolation
Human genomic libraries from the PromoterFinder Walking Kit (Clontech, Palo Alto, CA, USA) were used to isolate and clone the CyP40 promoter region. The PromoterFinder libraries consist of adapter-ligated genomic DNA fragments digested with 5 different restriction enzymes (Siebert et al 1995) . Two antisense primers specific to the 5Ј end of the published CyP40 cDNA sequence (Kieffer et al 1993) , GSP1 (5Ј-ACG-GGT-GCG-ACA-TCT-TGA-CTT-GCA-GAC-G-3Ј) and GSP2 (5Ј-CGG-AAT-ATC-AGA-GTA-CCT-AGT-GGC-CGC-C-3Ј) were used with the sense primers specific to the adaptor ligated to the genomic DNA in nested long-distance polymerase chain reaction (PCR) with DNA template from all 5 genomic libraries. Thermal cycling with the GSP1 primer was performed for 7 cycles of denaturation at 94ЊC for 30 seconds and annealing/extension at 72ЊC for 4 minutes, followed by 32 cycles of denaturation at 94ЊC for 30 seconds and annealing/extension at 67ЊC for 4 minutes, followed by 67ЊC for an additional 4 minutes after the final cycle. The first PCR product was diluted 1/100 and used for the nested PCR. Thermal cycling conditions for the nested PCR were 5 cycles of denaturation at 94ЊC for 30 seconds and annealing/extension at 72ЊC for 4 minutes, followed by 22 cycles of denaturation at 94ЊC for 30 seconds and annealing/extension at 67ЊC for 4 minutes, followed by 67ЊC for an additional 4 minutes after the final cycle. A 5-kb nested PCR product from the ScaI library was cloned into the pGEM-T vector (Promega Corp, Madison, WI, USA) to give plasmid pGEM-T CyP40/5. The CyP40 insert in this plasmid was sequenced in both directions with the pUC/M13 forward and reverse sequencing primers and internal primers using the Big Dye Terminator ready reaction sequencing kit (Perkin-Elmer Corp, Norwalk, CT, USA). The 3Ј sequence of the 5-kb fragment was compared with the published cDNA sequence for CyP40 for verification.
Primer extension analysis
The CyP40 transcription start site was determined using the avian myeloblastosis virus (AMV) Reverse Transcrip- Nucleotide sequence of the 5Ј-flanking region of the human CyP40 gene. Nucleotides in the 5Ј-flanking region are numbered with respect to the 3Ј major transcriptional start site that is denoted as ϩ1. The coding sequence of the first exon is shown as codon triplets. Restriction enzyme sites used to generate constructs are underlined. Sequences bearing close similarity to transcription factor binding sites (Ap1, Ap2, NF-B, Ets, Sp1) are italicized and in bold. Putative estrogen response elements (ERE half-sites and the Alu-ERE) are in bold and double underlined. The GT repeat and the Alu-repeat region are boxed, the latter in broken lines. The oligonucleotides, GSP1 and GSP2, used for PromoterFinder walking and primer extension analysis, are shown as arrowed lines. The 5Ј ends of deletion constructs (Ϫ1053, Ϫ686, Ϫ390, Ϫ166, Ϫ74, Ϫ51, Ϫ30, and ϩ1) and the common 3Ј end at ϩ49 are indicated by arrowheads (↓).
tase Primer Extension System (Promega). The primer, GSP1 (Fig 1) , which is complementary to the 5Ј end of the human CyP40 cDNA was end-labeled with (␥-32 P) adenosine triphosphate (ATP; 3000 Ci/mmol, Amersham Life Science, Amersham, UK) using T4 polynucleotide kinase. The 32 P-labeled GSP1 was annealed to 10 g of poly(A) ϩ RNA isolated from BT20 breast cancer cells using the QuickPrep Micro mRNA purification kit (Pharmacia Biotech, Uppsala, Sweden). The hybrids were extended by AMV reverse transcriptase and the extended products were analyzed on an 8% polyacrylamide 7 M urea sequencing gel along with end-labeled dephosphorylated X174 HinfI DNA markers (Promega) run concurrently to facilitate determination of product size. In order to localize transcriptional start sites, chain termination sequencing reactions using the primer GSP1, the plasmid pGEM-T CyP40/5, and the Sequenase Version 2.0 sequencing kit (United States Biochemical, Cleveland, OH, USA) were run in parallel.
Plasmid construction
The human CyP40 promoter-luciferase fusion plasmids were constructed by subcloning into the polylinker region of the pGL3-Basic vector (Promega) the following restriction fragments from the plasmid pGEM-T CyP40/5: (Ϫ1053/ϩ49) SacI/SmaI fragment, (Ϫ686/ϩ49) SmaI/ SmaI fragment, (Ϫ390/ϩ49) KpnI/SmaI fragment. To determine the specific elements in the most proximal region of the CyP40 promoter, 5 consecutive fragments were am-plified by PCR using sense primers Ϫ166 (5Ј-GGG-GTA-
, and antisense primer GSP1 (the locations of the primers are shown in Fig 1B) . KpnI sites were added to the 5Ј end of each primer for cloning purposes. The purified PCR products were KpnI/SmaI digested and ligated into the KpnI/SmaI site of the pGL3-Basic luciferase vector. For mutational analysis, CyP40-luciferase constructs were generated with the Ets motifs mutated by PCR. Mutant primers were used that were similar to the Ϫ51 sense primer above but contained altered Ets core sequences (M1 and M3, the 5Ј-GGAA-3Ј to 5Ј-TTAA-3Ј; M2, the 5Ј-TTCC-3Ј to 5Ј-TTAA-3Ј) as shown below:
51M1: 5Ј-GGGGTACCTTAAGTCAGGCCATGGCTT-CCGGTTCTTG-3Ј 51M2: 5Ј-GGGGTACCGGAAGTCAGGCCATGGCT-TAAGGTTCTTG-3Ј 51M3: 5Ј-GGGGTACCGGAAGTCAGGCCATGGCTT-CCGGTTCTTGCGTCTTAAGTG-3Ј 51M12: 5Ј-GGGGTACCTT AAGTCAGGCCATGGCT-TAAGGTTCTTG-3Ј 51M23: 5Ј-GGGGTACCGGAAGTCAGGCCATGGCT-TAAGGTTCTTGCGTCTTAAGTG-3Ј 51M123: 5Ј-GGGGTACCTT AAGTCAGGCCATGG-CTTAAGGTTCTTGCGTCTTAAGTG-3Ј KpnI sites were added to the 5Ј end of each primer for cloning purposes. GSP1 was used as the antisense primer. The purified PCR products were KpnI/SmaI digested as above and cloned into the KpnI/SmaI site of the pGL3-Basic luciferase vector. All plasmids were sequenced to confirm deletion end points and intended mutations within the CyP40 promoter sequence. The plasmids were purified to transfection quality using the Qiagen plasmid Maxi Kit (Qiagen, Germany). The CMV-GABP␣ and CMV-GABP␤ expression vectors used for the cotransfection experiments were kind gifts from Dr Thomas Brown (Pfizer Central Research, Groton, CT, USA).
Cell culture, transient transfections, luciferase, and chloramphenicol acetylase transferase assays
The following cell lines were used for transfection: the human breast cancer cell line, MCF-7 (Michigan Cancer Foundation, Detroit, MI) maintained in phenol red free Dulbecco modified Eagle medium (DMEM; Trace Biosciences, Sydney, Australia) and 5% charcoal-stripped fetal bovine serum (FBS); the cervical carcinoma cell line, HeLa, the lung carcinoma cell line, A549, and the African green monkey kidney Cos1 cells (all from the American Type Culture Collection, Rockville, MD, USA and maintained in DMEM with 5% FBS); and the human breast cancer cell line, BT-20 (American Type Culture Collection) maintained in Eagle minimum essential medium (EMEM; Trace Biosciences) with 10% FBS. For transient transfections, cells were plated onto 6-well plates and grown to 30%-40% confluence prior to transfection. The cells were transfected 24 hours later using FuGENE 6 transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA) with 1 g of appropriate luciferase/ CyP40 promoter construct and 100 ng of pcDNA plasmid (Invitrogen, Carlsbad, CA, USA) used to correct for transfection efficiency. Luciferase and chloramphenicol acetyl transferase (CAT) assays were performed after 48 hours. For the assays, cells were washed in phosphate-buffered saline (PBS) and resuspended in reporter lysis buffer (10 mM Tris HCl pH 8.0, 1 mM ethylenediamine-tetraacetic acid [EDTA] , 150 mM NaCl, 0.65% NP40). After a brief centrifugation, supernatants were used as samples. Luciferin substrate (60 g/mL) was made up in a working solution with 5 mM adenosine triphosphate (ATP) and assay buffer (25 mM glycylglycine, 15 mM MgSO 4 pH 7.8). The samples were added to the substrate just before counting in a ␤ counter (30 seconds, single photon mode) for luciferase activity. CAT activity was determined according to the Promega protocol using 14 C-labeled chloramphenicol (Amersham) at 0.05 mCi/mL. The luciferase activities were normalized to those of CAT and expressed as the percentage of the control plasmid.
Preparation of nuclear extract
Nuclear extract used in electrophoretic mobility shift analysis (EMSA) was prepared from HeLa cells grown in 75 cm 2 flasks to approximately 90% confluence. Cells were scraped off, washed in ice cold PBS, and transferred to an Eppendorf tube and spun for 10 seconds at full speed in a microfuge. The pellet was resuspended in 400 L of cold 10 mM HEPES pH 7.9 buffer containing 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), and a protease inhibitor cocktail (0.2 mM phenylmethylsulfonyl fluoride [Boehringer-Mannheim, Mannheim, Germany], 10 g/mL leupeptin [Sigma], 5 g/mL aprotinin [Sigma] and 5 g/mL pepstatin A [Sigma] ). The cells were allowed to swell on ice for 10 minutes and were then spun for 10 seconds at full speed. The supernatant was discarded and the pellet was resuspended in 200 L of ice cold 20 mM HEPES pH 7.9 buffer containing 25% glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, plus protease inhibitors as described above. After incubating on ice for 20 minutes, the suspension was centrifuged at 10 000 ϫ g for 2 minutes at 4ЊC. The clear supernatant was then collected and stored in aliquots at Ϫ80ЊC until further use. Protein concentrations were determined using the Bradford assay (Bio-Rad, Richmond, CA, USA) and bovine serum albumin standards (Sigma).
Wild-type and mutated oligonucleotides used in EMSA
The following double-stranded CyP40 oligonucleotides were synthesized for use in EMSA experiments. Underlined nucleotides indicate changes from the wild-type sequence. Only the sense sequences are listed here:
CyP40 WT: 5Ј-GCGGTGCCGGAAGTCAGGCCATGG-CTTCCGGTTCTTGCGT-3Ј M1: 5Ј-GCGGTGCCTT AAGTCAGGCCATGGCTTC-CGGTTCTTGCGT-3Ј M2: 5Ј-GCGGTGCCGGAAGTCAGGCCATGG-CTTAAGGTTCTTGCGT-3Ј M12: 5Ј-GCGGTGCCTT AAGTCAGGCCATGGC-TTAAGGTTCTTGCGT-3Ј Ets3: 5Ј-GCGTCGGAAGTGGCCGGTCAGCGTCGC-TGC-3Ј Synthetic oligonucleotides corresponding to the Ets-1 binding site from the human p53 gene promoter (Venanzoni et al 1996) , PEA3 (Wasylyk et al 1990) , and Pu1 (Kominato et al 1995) consensus binding sites used for competition studies were as follows:
p53: 5Ј-GATATTACGGAAAGCCTTCCTAAAAAAT-G-3Ј PEA3: 5Ј-GCGAGCAGGAAGTTCGACG-3Ј Pu1: 5Ј-GCATAAAGGGGAAGTTGTAG-3Ј
Electrophoretic mobility shift analysis EMSA was performed as follows: 200 ng of doublestranded probe was end-labeled with ␣-[ 32 P]-deoxycytidine 5Ј-triphosphate (dCTP; 3000 Ci/mmol) and Klenow DNA polymerase (Promega). Labeled probe (0.3 ng, 50 000 cpm) was added to the binding reaction mix (10 mM HEPES, 25 mM KCl, 2% Ficoll, 2% glycerol, 0.5 g/mL of poly(dI)-(dC), 0.4% bovine serum albumin [BSA]) along with 2 g of HeLa nuclear extract and the mixture was incubated for 30 minutes at room temperature. The reaction mixture (total volume of 15 L) was separated on a 4% polyacrylamide gel with 0.5% TBE buffer (90 mM Tris borate, 2 mM EDTA pH 8.0) at 240 V for 2 hours. The gel was subsequently vacuum-dried and autoradiographed at Ϫ80ЊC with intensifying screens. For competition experiments, the molar excess of unlabeled competitor DNA was added 10 minutes prior to the addition of the labeled probe. For supershift experiments, the antibody was preincubated with the reaction mixture at 4ЊC for 3 hours prior to the addition of the labeled probe. The Ets-1/Ets-2, Pu1, and PEA3 antibodies used in these experiments were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). Rabbit polyclonal antibodies directed against recombinant GABP␣ and GABP␤ were kind gifts from Dr Thomas Brown (Pfizer Central Research, Groton, CT, USA).
RNA isolation and Northern analysis
Tissue culture cells were washed in ice cold PBS and total RNA was extracted by guanidinium isothiocyanate and phenol-chloroform treatment followed by isopropanol precipitation. Northern blot analysis was carried out as follows: total RNA (30 g) was electrophoresed through a 1% denaturing agarose gel and then transferred by overnight capillary blotting to a Zeta Probe GT membrane (Bio-Rad). For each probing, the membrane was prehybridized for 5 hours at 42ЊC in hybridization solution without probe and then hybridized overnight at 42ЊC with fresh hybridization solution containing random primer-generated 32 P-labeled probe. Hybridization solution consisted of 50% formamide, 5ϫ Denhardts, 1% (wt/ vol) sodium dodecyl sulphate (SDS), 1.5ϫ SSPE (225 mM NaCl, 16 mM NaH 2 PO 4 , 1.5 mM EDTA pH 7.4), 0.25 mg/ mL salmon sperm DNA (Sigma), 0.2 mg/mL tRNA (Roche), and 10% (wt/vol) dextran sulphate (Sigma). Probes used were a 1.2-kb human CyP40 cDNA fragment encompassing the entire open-reading frame (Kieffer et al 1993) and incorporating PCR-engineered terminal XbaI recognition sites for cloning purposes, a 337-bp human FKBP52 cDNA fragment (FKBP52/337) released by HindIII/BamHI digestion of the full-length cDNA (Peattie et al 1992) and a 1.1-kb EcoRI/BamHI cloned fragment of the rat 18S ribosomal RNA gene (Katz et al 1983) . The membranes were washed at high stringency in 0.1ϫ standard saline citrate (SSC; 15 mM NaCl, 1.5 mM sodium citrate pH 7.0), 0.1% (wt/vol) SDS at 60ЊC, and exposed to Kodak X-OMAT film at Ϫ70ЊC. Membranes were probed initially for CyP40 and then, sequentially after stripping, for FKBP52 and 18S rRNA. mRNA signals were quantitated by densitometric scanning using ImageQuant software (Molecular Dynamics Inc, Sunnyvale, CA, USA).
RESULTS
Isolation of CyP40 promoter
Application of the PromoterFinder protocol (Siebert et al 1995) in a nested PCR reaction with CyP40 gene-specific primers GSP1 followed by GSP2 (Fig 1) generated amplification products of approximately 1.2 kb and 5 kb in size from the EcoRV and ScaI adaptor-ligated libraries, respectively. The full sequence (4981 bp) of the 5-kb fragment has been submitted to GenBank (accession number AF112974). Sequence analysis of the 3Ј end of the 5-kb fragment showed the sequence to be identical to that re-ported for the CyP40 gene by Yokoi et al (1996) except for the GT repeat region (Fig 1) . We identified 19 GT repeats compared with 21 GT repeats reported by Yokoi et al. The CyP40 promoter region showed no clear TATA or CAAT box motifs, but has putative binding sites for Sp1, Ap1, Ap2, Ets, and other sites as indicated in Figure 1 . The CyP40 promoter contains sequences that resemble estrogen receptor element half-sites. An imperfect estrogen responsive element (ERE) exists within an Alu repetitive sequence (Ϫ640 to Ϫ628) previously identified in the CyP40 gene promoter by Yokoi et al (Fig 1, denoted Alu-ERE). This ERE-related element (5Ј-GGTCAnnnTGGTC-3Ј) diverges from the palindromic vitellogenin A2 ERE (5Ј-GGTCAnnnTGACC-3Ј) by 2 base pairs. An ERE halfsite (5Ј-TGACC-3Ј) is located 9 base pairs downstream of the imperfect ERE (Fig 1) . Together, these elements are included within a 27-bp sequence (Ϫ640 to Ϫ614) that is homologous apart from a single base pair mismatch, to a BRCA 1 Alu-related genomic sequence previously shown to function as an efficient estrogen receptor-dependent enhancer (Norris et al 1995) .
Primer extension analysis was performed using poly(A) ϩ RNA of human breast cancer BT20 cells and gave nucleotide fragments (data not shown) that are consistent with the 5Ј end determined from the sequence of the original cDNA of human CyP40 isolated by Kieffer et al (1993) . The location of this transcription start site is indicated in Figure 1 . Examination of the sequence immediately upstream of the transcription initiation site revealed that the CyP40 gene promoter lacks a typical TATA consensus motif, but is rich in GC bases and contains a putative Sp1 site and potential regulatory elements for Ets domain proteins.
Functional analysis of the human CyP40 5-flanking region
To define functionally important regulatory elements involved in the basal expression of the human CyP40 gene, serial deletion mutants of the CyP40 5Ј-flanking region, ranging from Ϫ1053 to ϩ1, were fused to a luciferase reporter. The 3Ј end of these promoter constructs corresponded to position ϩ49 and terminated 53 bp before the first ATG of the CyP40 open-reading frame. These constructs were transfected into BT-20 and MCF-7 breast cancer cells, which display high and modest levels of CyP40 mRNA expression and protein, respectively (Ward et al 1999) . As a control, the promoterless reporter plasmid, pGL3-Basic, was transfected into parallel cultures of each cell line. Using the same constructs, characterization of CyP40 promoter activity was extended to the HeLa cervical carcinoma cell line and the lung carcinoma cell line, A549. The largest construct (Ϫ1053 to ϩ49) showed strong promoter activity in all 4 cell lines (Fig 2) . Deletion of bases to Ϫ686 produced a general decrease in luciferase activity and a further deletion to Ϫ390 resulted in increased promoter activity in each of the cell lines. This could signify the presence of weak silencer elements between Ϫ686 and Ϫ390, but this apparent inhibitory influence was not explored further in the present studies. Deletions between Ϫ390 and Ϫ51 had only a modest effect on luciferase expression, although the Ϫ51 CyP40 promoter construct displayed an approximately 70% decrease in luciferase activity when compared with the Ϫ1053 construct in the MCF7 and A549 cell lines (Fig 2) . Deletion of the region from Ϫ51 to Ϫ30 virtually abolished all luciferase activity in the 4 cell lines, with the level of promoter activity comparable to that seen with the pGL3-Basic vector. These results therefore define a region between Ϫ51 and Ϫ30 that is critical for CyP40 basal promoter activity. Computer-aided analysis of this critical region and the adjacent 3Ј sequence using the TFSearch program (Heinemeyer et al 1998) , revealed the presence of 3 potential Ets binding sites with the core sequence of 5Ј-GGA-3Ј centered at Ϫ48, Ϫ30, and Ϫ15 relative to the transcription start site. The central Ets sequence exists in a palindromic arrangement with the upstream site, the sites being separated by 17 bp. On the other hand, the central motif forms an inverted palindrome with the third Ets binding site located a further 16 bp downstream (Fig 1) .
Mutational analysis of the Ets binding sites of the CyP40 proximal promoter
To test the importance of the three Ets binding sites present in the CyP40 minimal promoter, we sequentially altered the stringently conserved Ets 5Ј-GGA-3Ј consensus sequence to TTA in the Ets motifs within the Ϫ51 CyP40 promoter construct. The effect of these mutations on CyP40 minimal promoter activity was examined by transient transfection of the mutated constructs into MCF-7 cells (Fig 3) . Mutation of the upstream Ets motif (M1) resulted in 80% loss of luciferase activity, whereas alteration of the central Ets site (M2) reduced activity by approximately 70% compared with the luciferase activity of the wild-type Ϫ51 CyP40 promoter construct. Mutation of the third Ets site was effective in reducing the promoter activity by approximately 55%. However, mutation of 2 putative Ets binding sites together (M12 or M23) or mutation of all 3 Ets sites led to a complete loss of transcription from the minimal Ϫ51 to ϩ49 promoter fragment, reducing it to a level comparable to that of the Ϫ30 CyP40 promoter construct, which is essentially nonfunctional. This suggests a crucial role for the Ets binding sites in the regulation of the CyP40 gene. 
Characterization of binding of transcription factors to the CyP40 promoter by EMSA
Based on the above observations, we examined more closely the critical region, Ϫ51 to Ϫ30, which contains the essential Ets binding sites for interaction with HeLa cell nuclear factors by EMSA. The CyP40 probe containing the first and second Ets motifs was designed to include sequences on either side of the Ets core motif, 5Ј-GGA-3Ј. The flanking sequences have been shown to help determine recognition by Ets domain proteins and provide additional space for the stabilization of potential DNA-protein interactions at Ets binding sites (Wasylyk et al 1993) . Nuclear proteins from HeLa cells formed approximately 5 complexes with the CyP40 probe, all of which were competed out with an excess of unlabeled wild-type oligonucleotide, suggesting that they were specific interactions (Fig 4A, lane 3) . Unlabeled oligonucleotides with a mutation in the first Ets core sequence (M1) efficiently inhibited the formation of the nuclear protein-DNA complexes (Fig 4A, lane 4) , whereas an oligonucleotide with a mutation in the second Ets core sequence (M2) was much less effective (Fig 4A, lane 5) . However, the doublemutated oligonucleotide, M12, failed to inhibit the protein-DNA complexes (Fig 4A, lane 6) , suggesting that all the complexes formed with the CyP40 DNA probe and HeLa nuclear proteins depended on the presence of the 2 intact Ets binding sites.
Competition experiments with the Ets-1 binding sitecontaining oligonucleotide from the human p53 gene promoter (Venanzoni et al 1996) failed to inhibit EMSA complex formation, but oligonucleotides containing consensus PEA3 (Wasylyk et al 1990) and Pu1 (Kominato et al 1995) binding sites were effective in inhibiting the nuclear protein-CyP40 DNA interactions (Fig 4A, lanes 8 and 9) . This suggests that the HeLa cell nuclear proteins binding to the radiolabeled CyP40 probe also bind to other Ets factor binding sites such as PEA3 and Pu-1, but not Ets-1. However, addition of polyclonal antibodies directed against various members of the Ets family (Ets-1, Ets1/2, PEA3, and Pu1), failed to modify the nuclear protein complexes formed with CyP40 DNA probe (Fig 4A, lanes 10-13) . From the competition studies it was evident that nuclear proteins from HeLa cells bound to the Ets motifs in the CyP40 promoter, but the identification of the specific Ets binding factor could not be determined by the above supershift experiments.
Typically, Ets genes are expressed in a temporal and tissue-specific fashion with some found most abundantly in cells of lymphoid or erythroid origin (eg, Pu1) and others expressed preferentially in epithelial tissues (eg, elk-1, PEA3, ER81, GABP␣; Scott et al 1994) . The ubiquitous Ets transcription factor, GABP␣, identified in HeLa and in several breast cancer cell lines, was considered a likely candidate for binding to the CyP40 minimal promoter. Comparison of the 3 Ets sites in the CyP40 promoter with the optimal DNA-binding site for GABP (Brown and McKnight 1992) shows that the first site (Ϫ48) is a perfect match, whereas the other 2 Ets sites share 8 out of 9 bases with the consensus GABP binding motif (Table 1) . Antibodies raised against both GABP␣ and GABP␤, when used in a gel shift experiment with the CyP40 probe, resulted in the generation of a supershifted complex at the expense of complex I and in a slight reduction in the formation of all the other complexes ( Fig 4B, lanes 2-5) . These results indicate that complex I, and possibly the other complexes, result from DNA binding of GABP␣ and GABP␤ and may correspond to the binding of distinct heteromeric forms of GABP .
The ability of the mutant oligonucleotides M1 and M2 to form the 5 nuclear protein complexes was then determined in a gel shift assay (Fig 4B) . Mutant probes M1 and M2 failed to form the slowest migrating complex I (Fig 4B, lanes 6 and 10) . The complexes II, IV, and V were supershifted by anti-GABP␣ antibody using either of the mutated probes (Fig 4B, lanes 6-13) .
Similar EMSA studies of the third Ets at Ϫ15 using a separate oligonucleotide (Ets3), confirmed specific interaction with GABP (data not shown).
Effect of GABP overexpression on CyP40 transcription
The transcriptional effect of GABP factors on the CyP40 promoter was evaluated by cotransfection of the GABP␣ and GABP␤ expression plasmids with the CyP40 minimal promoter construct, Ϫ51 CyP40/LUC, into MCF-7, HeLa, and Cos1 cells. Western analysis of nuclear proteins from cells transfected with empty vector or GABP␣ and GABP␤ expression plasmids demonstrated specific overexpression of the GABP proteins (data not shown). Figure  5A shows that coexpression of GABP␣ and GABP␤ subunits enhanced CyP40 basal promoter activity by 3.5-, 2-, and 24-fold in MCF-7, HeLa, and Cos1 cells, respectively. Cotransfection experiments in MCF-7 cells showed that the mutated CyP40 promoter constructs, which contain either 1 or 2 altered Ets sites, also displayed increased luciferase activity in the presence of ectopically expressed GABP (Fig 5B) . However, deletion of all Ets motifs resulted in a loss of the GABP-mediated increase in CyP40 promoter activity. The pGL3/promoter plasmid driven by the SV40 promoter failed to respond positively in the P-end labeled wild-type oligonucleotide (Ϫ57 to Ϫ18) was incubated with nuclear extracts from HeLa cells preincubated with the antibodies (lanes 3-5) for supershift analysis, 32 Pend labeled mutant M1 oligonucleotide (lanes 7-9) and 32 P-end labeled mutant M2 oligonucleotide (lanes 11-13) were similarly used for supershift analysis. Lane 1 shows free probe in the absence of nuclear extract, whereas lanes 2, 6, and 10 show HeLa nuclear protein complex formation with the wild-type CyP40 and mutated probes, M1 and M2, respectively. presence of the GABP␣/GABP␤ expression plasmids (data not shown), further confirming the specific role of GABP␣ and GABP␤ in the regulation of the CyP40 gene.
Expression of GABP␣/GABP␤ in Cos1 cells induces CyP40 mRNA
We next determined if the increased GABP␣/GABP␤ expression would be sufficient to up-regulate endogenous CyP40 mRNA levels in Cos1 cells, which showed a 24-fold enhancement in CyP40 promoter activity when cotransfected with the GABP␣/GABP␤ expression plasmids (Fig 5A) . Cos1 cells transfected either with empty vector or with GABP␣ and GABP␤ expression plasmids were harvested for total RNA. Northern analysis demonstrated a dramatic increase in CyP40 mRNA expression in GABP␣/GABP␤-transfected cells (Fig 6) . In contrast, FKBP52 mRNA expression was unaltered under the same treatment conditions. These results confirm the specific role of GABP␣/GABP␤ as a positive regulator of CyP40 gene expression.
DISCUSSION
Using PCR-based methodology we have isolated a 5-kb genomic segment 5Ј of the first exon of the human CyP40 gene. Sequence analysis of the 3Ј end of this fragment released by restriction endonuclease digestion confirmed the sequence previously reported for the CyP40 proximal promoter by Yokoi et al (1996) . We have defined an additional approximately 3-kb region upstream of that described earlier (Yokoi et al 1996) . A minor difference between the 2 sequences was a reduction (21 to 19) in the number of dinucleotide repeats identified within a GT repeat region, which we have recently confirmed as a useful polymorphic marker (GenBank accession number U82274) for the CyP40 gene . In addition to putative control elements for Ap1 and Sp1 previously described by Yokoi et al (1996) , consensus sites for several transcription factors, including Ets, Ap2, and NF-B were noted (Fig 1) . The presence of imperfect estrogen response elements in the CyP40 promoter suggests the possibility of estrogen induction via these sites and this is currently under investigation in our laboratory. Functional characterization of the CyP40 gene promoter allowed Table 1 Comparison of the optimal GABP␣ binding site with the three Ets binding sites present in the CyP40 minimal promoter
GABP, GA-binding protein; CyP40, cyclophilin 40.
the delineation of a ϳ50 bp sequence adjacent to the transcription start site to be essential for basal promoter activity. Three tandemly arranged Ets sites within this critical region were identified as binding elements for GABP, a heteromeric Ets-related transcription factor. Functional studies of this proximal promoter sequence, in combination with mutational analysis, confirmed these sites to be crucial for basal promoter function and that they mediate the increased promoter activity seen in the presence of exogenously expressed GABP. Collectively, our results are consistent with a key role for GABP in the regulation of CyP40 expression. GABP is a cellular heteromeric DNA-binding protein involved in the activation of nuclear genes encoding mitochondrial proteins (Virbasius et al 1993) , adenovirus early genes (Watanabe et al 1993) , and herpes simplex virus immediate-early genes (Triezenberg et al 1988) . A role for GABP in the oxytocin receptor gene expression has recently been described (Hoare et al 1999) . GABP is constitutively expressed in most cell types (LaMarco et al 1991) and is an attractive candidate for coordination of globally expressed sets of housekeeping genes such as CyP40. Tandemly arranged GABP binding sites have been detected in several other promoters (Avots et al 1997; Bannert et al 1999) and the interaction between 2 or more heterodimeric GABP factors appears to be important for activation by these factors. As proposed by Brown and McKnight (1992) , GABP-specific recruitment (and exclusion of other factors with overlapping sequence specificity) may be achieved by the repetition of GABP binding motifs. Our detection of multiple GABP binding sites in the CyP40 promoter is consistent with this proposal. The presence of 3 tandemly arranged GABP sites, together with the structural flexibility of the GABP heterocomplex (Gugneja et al 1995) , may offer several options for regulating CyP40 basal promoter activity or GABP␣ and GABP␤ expression plasmids (B) were harvested for total RNA 48 hours after transfection. Thirty micrograms of total RNA was subjected to Northern analysis and sequentially probed for CyP40, FKBP52, and 18S RNA, the latter to ensure equal loading of total RNA in each experiment.
through the cooperative interaction of GABP with any 2 of the sites.
The CyP40 promoter lacks traditional TATA and CAAT elements and is characterized by a high GC content accompanied by frequent clusters of the CpG dinucleotide, which is believed to play a key role in housekeeping gene expression (Bird 1986 ). Many TATA-less promoters have been shown to contain typical initiator elements, which are short, conserved sequences that are bound by proteins of the transcriptional machinery. Some of these promoters, including those for type IV collagenase, thymidylate synthetase, and cytochrome C oxidase subunit IV, possess Ets binding motifs near their transcription start sites, suggesting their role as initiator elements (Huhtala et al 1990; Jolliff et al 1991; Virbasius et al 1993) . Transcriptional activators such as GABP, which are bound near transcription start sites, may therefore provide an additional interface for the recruitment of TFIID (or other basal initiation factors). The close proximity of the GABP binding sites to the transcriptional start site in the CyP40 promoter suggests that these binding sites may function cooperatively as an initiator element in CyP40 expression.
We have previously noted the variable expression of CyP40 mRNA in several breast cancer cell lines and breast tumor tissues (Ward et al 1999) . A number of alternative or complementary mechanisms may contribute to GABP-mediated control over CyP40 expression in these specimens. Although GABP is ubiquitously expressed (LaMarco et al 1991) , basal CyP40 mRNA expression may be correlated with expression levels of GABP␣ and GABP␤ subunits, either of which may be limiting. In addition, recent reports that GABP may function as a methylation-sensitive transcriptional activator (Yokomori et al 1995 (Yokomori et al , 1998 suggests that GABP regulation of CyP40 gene expression may be dependent on the methylation status of CpG dinucleotides within the Ets binding sites in the CyP40 proximal promoter. GABP has been implicated as a downstream regulator of several genes by heregulin, a combinatorial ligand for the ErbB receptor family with growth stimulatory effects in breast cancer cells (Tzahar and Yarden 1998) . The transcriptional activation of acetylcholine receptor (Fromm and Burden 1998) and utrophin (Gramolini et al 1999) genes by heregulin occurs through the MAP-kinase pathway and requires conserved GABP binding sites within the proximal promoters of these genes. Heregulin enhances GABP␣ expression and increases the phosphorylation of both GABP subunits by MAP kinases in vivo (Schaeffer et al 1998) . GABP then might regulate CyP40 gene expression in a similar fashion by integrating diverse signals in response to mitogenic and stress-related stimuli.
In conclusion, we have shown that GABP is a key regulator of CyP40 gene expression and functions through a multiple binding site element located in the CyP40 proximal promoter. A significant finding is that GABP appeared to have little influence on the expression of FKBP52, a partner immunophilin with CyP40 in Hsp90-dependent signaling pathways associated with steroid receptor activity. We have therefore identified an important difference in the regulatory mechanisms that control CyP40 and FKBP52 expression in the cell. Further studies into the regulation of other Hsp90-binding TPR-containing immunophilins will provide important insights into mechanisms that control their relative cellular abundance. Such influences may impact not only the role of these immunophilins in steroid receptor assembly and function, but also on their more global role in cellular function.
